Caries Arresting Medicament — Medicament Application Guidelines
Scope: policy governing when topical caries-arresting medicaments (e.g., silver diamine fluoride) are considered appropriate dental treatment and the clinical contexts under which application may be performed; applies to Anthem dental benefit determinations and providers submitting claims or requests for review.
No material clinical or coverage changes in this revision.
Coverage Criteria — When Application Is Covered
Indications for caries arresting medicament application
Covered when ALL of the following are met:
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.